218 related articles for article (PubMed ID: 27471397)
1. Interleukin-32α inactivates JAK2/STAT3 signaling and reverses interleukin-6-induced epithelial-mesenchymal transition, invasion, and metastasis in pancreatic cancer cells.
Chen J; Wang S; Su J; Chu G; You H; Chen Z; Sun H; Chen B; Zhou M
Onco Targets Ther; 2016; 9():4225-37. PubMed ID: 27471397
[TBL] [Abstract][Full Text] [Related]
2. Luteolin decreases invasiveness, deactivates STAT3 signaling, and reverses interleukin-6 induced epithelial-mesenchymal transition and matrix metalloproteinase secretion of pancreatic cancer cells.
Huang X; Dai S; Dai J; Xiao Y; Bai Y; Chen B; Zhou M
Onco Targets Ther; 2015; 8():2989-3001. PubMed ID: 26527884
[TBL] [Abstract][Full Text] [Related]
3. The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro.
Huang C; Yang G; Jiang T; Zhu G; Li H; Qiu Z
Neoplasma; 2011; 58(5):396-405. PubMed ID: 21744993
[TBL] [Abstract][Full Text] [Related]
4. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract][Full Text] [Related]
5. α-Hederin inhibits interleukin 6-induced epithelial-to-mesenchymal transition associated with disruption of JAK2/STAT3 signaling in colon cancer cells.
Sun D; Shen W; Zhang F; Fan H; Xu C; Li L; Tan J; Miao Y; Zhang H; Yang Y; Cheng H
Biomed Pharmacother; 2018 May; 101():107-114. PubMed ID: 29477470
[TBL] [Abstract][Full Text] [Related]
6. Quercetin inhibits epithelial-mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial-mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells.
Yu D; Ye T; Xiang Y; Shi Z; Zhang J; Lou B; Zhang F; Chen B; Zhou M
Onco Targets Ther; 2017; 10():4719-4729. PubMed ID: 29026320
[TBL] [Abstract][Full Text] [Related]
7. Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway.
Kong G; Jiang Y; Sun X; Cao Z; Zhang G; Zhao Z; Zhao Y; Yu Q; Cheng G
Oncol Rep; 2017 Nov; 38(5):2647-2656. PubMed ID: 29048621
[TBL] [Abstract][Full Text] [Related]
8. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
9. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
10. Silencing of ITGB6 inhibits the progression of cervical carcinoma via regulating JAK/STAT3 signaling pathway.
Zheng X; Zhu Y; Wang X; Hou Y; Fang Y
Ann Transl Med; 2021 May; 9(9):803. PubMed ID: 34268416
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis.
Zhou QX; Jiang XM; Wang ZD; Li CL; Cui YF
Med Oncol; 2015 Apr; 32(4):105. PubMed ID: 25744243
[TBL] [Abstract][Full Text] [Related]
12. IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway.
Jiang M; Wang Y; Zhang H; Ji Y; Zhao P; Sun R; Zhang C
Thorac Cancer; 2018 May; 9(5):621-629. PubMed ID: 29575809
[TBL] [Abstract][Full Text] [Related]
13. IL-6 promotes epithelial-to-mesenchymal transition of human peritoneal mesothelial cells possibly through the JAK2/STAT3 signaling pathway.
Xiao J; Gong Y; Chen Y; Yu D; Wang X; Zhang X; Dou Y; Liu D; Cheng G; Lu S; Yuan W; Li Y; Zhao Z
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F310-F318. PubMed ID: 28490530
[TBL] [Abstract][Full Text] [Related]
14. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration.
Wang B; Liu T; Wu JC; Luo SZ; Chen R; Lu LG; Xu MY
Biomed Pharmacother; 2018 Feb; 98():214-221. PubMed ID: 29268242
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-32α induces migration of human melanoma cells through downregulation of E-cadherin.
Lee J; Kim KE; Cheon S; Song JH; Houh Y; Kim TS; Gil M; Lee KJ; Kim S; Kim D; Hur DY; Yang Y; Bang SI; Park HJ; Cho D
Oncotarget; 2016 Oct; 7(40):65825-65836. PubMed ID: 27589563
[TBL] [Abstract][Full Text] [Related]
16. Sesamolin exerts anti-proliferative and apoptotic effect on human colorectal cancer cells via inhibition of JAK2/STAT3 signaling pathway.
Wu D; Wang XP; Zhang W
Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):96-100. PubMed ID: 31472054
[TBL] [Abstract][Full Text] [Related]
17. PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway.
Gao S; Hu J; Wu X; Liang Z
Biomed Pharmacother; 2018 Dec; 108():618-624. PubMed ID: 30243096
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan.
Alaaeldin R; Ali FEM; Bekhit AA; Zhao QL; Fathy M
Molecules; 2022 Nov; 27(22):. PubMed ID: 36431925
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 expression by interactions between gynecologic cancer cells and human mesenchymal stem cells promotes epithelial-mesenchymal transition.
So KA; Min KJ; Hong JH; Lee JK
Int J Oncol; 2015 Oct; 47(4):1451-9. PubMed ID: 26316317
[TBL] [Abstract][Full Text] [Related]
20. Procyanidins mediates antineoplastic effects against non-small cell lung cancer via the JAK2/STAT3 pathway.
Wu Y; Liu C; Niu Y; Xia J; Fan L; Wu Y; Gao W
Transl Cancer Res; 2021 May; 10(5):2023-2035. PubMed ID: 35116524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]